Daxor Corp. (DXR) Income Statement

Click line-items for a historical chart and %

Operating Revenues – equipment sales and related services	260.23K
Operating Revenues – cryobanking and related services	80.68K
Total Revenues	340.91K
Cost of equipment sales and related services	136.17K
Cost of cryobanking and related services	13.21K
Total Cost of Sales	149.38K
Gross Profit	191.53K
Research and development-equipment sales and related services	591.04K
Research and development-cryobanking and related services	46.01K
Total Research and Development Expenses	637.05K
Selling, general, and administrative- equipment sales and related services	639.89K
Selling, general, and administrative- cryobanking and related services	175.66K
Total Selling, General & Administrative Expenses	815.55K
Total Operating Expenses	1.45M
Loss from Operations	-1.26M
Dividend income-investment portfolio	645.79K
Realized gains on sale of securities and options, net	253.51K
Mark to market adjustments on short sales of options	-6.61M
Other revenues	3.09K
Interest expense	-29.77K
Administrative expense relating to portfolio investments	-31.44K
Total Other Income	-5.77M
(Loss) Income before Income Taxes	-7.03M
Income Tax (Benefit)	-2.85M
Net (Loss) Income	-4.18M
Net (Loss) Income	-4.18M
Unrealized Gain (Loss) on Securities Held for Sale, Net of Deferred Income Taxes	-3.71M
Comprehensive Income (Loss)	-7.89M
Weighted average number of shares outstanding – basic and diluted (in Shares)	4.22M
Net (Loss) Income per common equivalent share – basic and diluted (in Dollars per share)	-0.99
Dividends paid per common share (in Dollars per share)	0

This is a StreetInsider.com Premium Only Page